Company intelligence / Profile preview

Uniphar Group

Ownership: Private
Employees: ~3500
Development stage: Commercial

Overview

Uniphar operates at commercial scale as a leading healthcare services provider specializing in pharmaceutical and medtech distribution, market access solutions, supply chain management, pharmacy retail support, and specialist sourcing of medicines across Europe and globally. The group partners with over 200 multinational clients—including nine of the top ten global pharma companies—and delivers to more than 160 countries. It has recently expanded into cell and gene therapy logistics/projects but does not develop its own therapeutics.

Modalities: Cell and gene therapiesGeneral pharmaceutical productsMedical devices
Industry: Drug Discovery Services

Partnerships

Partners with nine of the top ten global pharmaceutical companiesPartners with seven of the top ten medical device companies

Beyond the preview

Go deeper on Uniphar Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uniphar Group.

Explore the full profile